From niche to organoid: Engineering bone tissues through microenvironmental insights
Xu Y., Sheng L., Zhu M., He Z., Yao X., Wu H.
Narrative Review, published in J Tissue Eng (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- J Tissue Eng (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40755459
- PMCID
- PMC12314253
- DOI
- 10.1177/20417314251358567
Abstract (original English)
The construction of bone organoids represents a transformative approach in tissue engineering, offering unprecedented opportunities for studying bone biology, disease modeling, and regenerative medicine. The intricate understanding of the skeletal microenvironment, or niche, which governs cellular behavior, tissue organization, and functional maturation, is critical important to construct bone organoid. This review explored insights into the skeletal microenvironment, including the roles of extracellular matrix components, mechanical cues, biochemical signaling, and cellular interactions. It also proposes a foundational strategy how advancements in biomaterials, extracellular matrix, and micro-structure have enabled the precise recapitulation of niche conditions, facilitating the development of physiologically relevant bone organoids. Furthermore, we highlight the applications of these organoids in drug screening, personalized medicine, and bone regeneration. By bridging the gap between niche biology and organoid engineering, this review underscores the potential of microenvironment-driven approaches to revolutionize bone tissue engineering and its translational impact.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.